PL373104A1 - Cefalosporyny - Google Patents

Cefalosporyny

Info

Publication number
PL373104A1
PL373104A1 PL03373104A PL37310403A PL373104A1 PL 373104 A1 PL373104 A1 PL 373104A1 PL 03373104 A PL03373104 A PL 03373104A PL 37310403 A PL37310403 A PL 37310403A PL 373104 A1 PL373104 A1 PL 373104A1
Authority
PL
Poland
Prior art keywords
cephalosporins
Prior art date
Application number
PL03373104A
Other languages
English (en)
Inventor
Gerd Ascher
Werner Heilmayer
Michael Schranz
Josef Wieser
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0216418A external-priority patent/GB0216418D0/en
Priority claimed from GB0222177A external-priority patent/GB0222177D0/en
Priority claimed from GB0223974A external-priority patent/GB0223974D0/en
Priority claimed from GB0223977A external-priority patent/GB0223977D0/en
Priority claimed from GB0223975A external-priority patent/GB0223975D0/en
Priority claimed from GB0223976A external-priority patent/GB0223976D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PL373104A1 publication Critical patent/PL373104A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
PL03373104A 2002-07-15 2003-07-14 Cefalosporyny PL373104A1 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0216418A GB0216418D0 (en) 2002-07-15 2002-07-15 Organic compound
GB0222177A GB0222177D0 (en) 2002-09-24 2002-09-24 Organic compounds
GB0223974A GB0223974D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223977A GB0223977D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223975A GB0223975D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223976A GB0223976D0 (en) 2002-10-15 2002-10-15 Organic compounds

Publications (1)

Publication Number Publication Date
PL373104A1 true PL373104A1 (pl) 2005-08-08

Family

ID=30119477

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03373104A PL373104A1 (pl) 2002-07-15 2003-07-14 Cefalosporyny

Country Status (22)

Country Link
US (1) US7485632B2 (pl)
EP (1) EP1529050B1 (pl)
JP (1) JP2005536499A (pl)
KR (1) KR20050037553A (pl)
CN (1) CN1678616A (pl)
AR (1) AR040545A1 (pl)
AT (1) ATE327239T1 (pl)
AU (1) AU2003250056A1 (pl)
BR (1) BR0312698A (pl)
CA (1) CA2492373A1 (pl)
CO (1) CO5680481A2 (pl)
DE (1) DE60305506T2 (pl)
EC (1) ECSP055538A (pl)
ES (1) ES2268429T3 (pl)
IL (1) IL166120A0 (pl)
MX (1) MXPA05000664A (pl)
NO (1) NO20050781L (pl)
PE (1) PE20040657A1 (pl)
PL (1) PL373104A1 (pl)
SI (1) SI1529050T1 (pl)
TW (1) TW200422044A (pl)
WO (1) WO2004007505A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000189171A (ja) * 1998-12-25 2000-07-11 Banyu Pharmaceut Co Ltd 新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタ―タンパク質
US10100068B2 (en) * 2014-04-16 2018-10-16 Sika Technology Ag Amidine group—or guanidine group—containing silane

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5093989A (pl) 1973-10-25 1975-07-26
ATE233268T1 (de) 1995-05-11 2003-03-15 Biochemie Gmbh Antibakterielle cephalosporinverbindungen
GB0301938D0 (en) * 2003-01-28 2003-02-26 Biochemie Gmbh Organic compounds

Also Published As

Publication number Publication date
US20050234233A1 (en) 2005-10-20
KR20050037553A (ko) 2005-04-22
SI1529050T1 (sl) 2006-10-31
ATE327239T1 (de) 2006-06-15
MXPA05000664A (es) 2005-04-25
DE60305506D1 (de) 2006-06-29
TW200422044A (en) 2004-11-01
AR040545A1 (es) 2005-04-13
US7485632B2 (en) 2009-02-03
HK1077299A1 (en) 2006-02-10
JP2005536499A (ja) 2005-12-02
CA2492373A1 (en) 2004-01-22
AU2003250056A1 (en) 2004-02-02
CN1678616A (zh) 2005-10-05
IL166120A0 (en) 2006-01-15
PE20040657A1 (es) 2004-11-08
ECSP055538A (es) 2005-03-10
WO2004007505A1 (en) 2004-01-22
NO20050781L (no) 2005-02-14
CO5680481A2 (es) 2006-09-29
BR0312698A (pt) 2005-05-03
DE60305506T2 (de) 2007-04-19
EP1529050B1 (en) 2006-05-24
ES2268429T3 (es) 2007-03-16
EP1529050A1 (en) 2005-05-11

Similar Documents

Publication Publication Date Title
HUS1600008I1 (hu) Cefémvegyületek
DE60311980D1 (en) Histondeacetylase-hemmer
DE50311874D1 (en) Spirocyclische cyclohexan-derivate
DE50312422D1 (en) Aryloxime
DE60315313D1 (en) Polytrimethylenetherester
AU2003249738A8 (en) Ostoscope
AU2003297193A8 (en) Meta-web
DE60303791D1 (en) Aza-arylpiperazine
DE50309217D1 (en) Benzimidazolderivate
AU2003252028A8 (en) Heterodiamondoids
AU2003279495A8 (en) Alert-modeling
DE50303619D1 (en) Reibschweissvorrichtung
PL373240A1 (pl) Poliizobutenoaminy
DE50308027D1 (en) Cyclohexyl-harnstoff-derivate
DE50313444D1 (en) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
DE50307787D1 (en) Isophthalsäurederivate
DE50311133D1 (en) Carbonsäureamide
DE50312412D1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamin-derivative
DE60224584D1 (en) Rotationsdämpfer
AU2003264900A8 (en) Cast-cutter
DE50310169D1 (en) Lingual-retainer
DE60310887D1 (en) Epilatorstreifen
DE50304964D1 (en) Handhobelmaschine
AU2002367810A8 (en) Bis-transition-metal-chelate-probes
AU2003262681A8 (en) Hemo-aide

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)